17. Nag M, Gajbhiye V, Kesharwani P, Jain NK. Transferrin
functionalized chitosan-PEG nanoparticles for targeted
delivery of paclitaxel to cancer cells. Colloids Surf
B Biointerfaces. 2016;148:363-370. doi: 10.1016/j.
colsurfb.2016.08.059.
18. Lin M, Wang D, Liu S, et al. Cupreous complex-loaded
chitosan nanoparticles for photothermal therapy and
chemotherapy of oral epithelial carcinoma. ACS Appl
Mater Interfaces. 2015;7(37):20801-20812. doi: 10.1021/
acsami.5b05866.
19. Mazzarino L, Loch-Neckel G, Bubniak Ldos S, et al.
Curcumin-loaded chitosan-coated nanoparticles as a
new approach for the local treatment of oral cavity cancer.
J Nanosci Nanotechnol. 2015;15(1):781-791.
20. Trif M, Florian PE, Roseanu A, et al. Cytotoxicity and
intracellular fate of PLGA and chitosan-coated PLGA
nanoparticles in Madin–Darby bovine kidney (MDBK)
and human colorectal adenocarcinoma (Colo 205) cells.
J Biomed Mater Res A. 2015;103(11):3599-3611. doi:
10.1002/jbm.a.35498.
21. Navarro SM, Darensbourg C, Cross L, et al. Biodistribution
of PLGA and PLGA/chitosan nanoparticles after repeat-
dose oral delivery in F344 rats for 7 days. Ther Deliv.
2014;5(11):1191-1201. doi: 10.4155/tde.14.79.
22. Navarro SM, Morgan TW, Astete CE, et al. Biodistribution
and toxicity of orally administered poly (lactic-co-glycolic)
acid nanoparticles to F344 rats for 21 days. Nanomedicine
(Lond). 2016;11(13):1653-1669. doi: 10.2217/nnm-2016-
0022.
23. Costea DE, Loro LL, Dimba EA, Vintermyr OK, Johannessen
AC. Crucial effects of fibroblasts and keratinocyte growth
factor on morphogenesis of reconstituted human oral
epithelium. J Invest Dermatol. 2003;121(6):1479-1486.
24. Ishkitiev N, Yaegaki K, Imai T, et al. High-purity hepatic
lineage differentiated from dental pulp stem cells in
serum-free medium. J Endod. 2012;38(4):475-480. doi:
10.1016/j.joen.2011.12.011.
25. Lee CP, Colombo JS, Ayre WN, Sloan AJ, Waddington
RJ. Elucidating the cellular actions of demineralised
dentine matrix extract on a clonal dental pulp stem
cell population in orchestrating dental tissue repair.
J Tissue Eng. 2015;6:2041731415586318. doi:
10.1177/2041731415586318. eCollection 2015.
26. Dufour A, Meas-Yedid V, Grassart A, Olivo-Marin JC.
Automated quantification of cell endocytosis using active
contours and wavelets. In: Pattern Recognition, 2008.
ICPR 2008. 19th International Conference on (pp. 1-4).
IEEE. USA: Tampa, FL; 2009
27. de Chaumont F, Dallongeville S, Chenouard N, et al. Icy:
an open bioimage informatics platform for extended
reproducible research. Nat Methods. 2012;9(7):690-696.
doi: 10.1038/nmeth.2075.
28. Virlan MJ, Miricescu D, Radulescu R, et al. Organic
nanomaterials and their applications in the treatment
of oral diseases. Molecules. 2016;21(2). pii: E207. doi:
10.3390/molecules21020207.
29. Friedman AJ, Phan J, Schairer DO, et al. Antimicrobial
and anti-inflammatory activity of chitosan–alginate
nanoparticles: A targeted therapy for cutaneous
pathogens. J Invest Dermatol. 2013;133(5):1231-1239.
doi: 10.1038/jid.2012.399.
30. Chronopoulou L, Massimi M, Giardi MF, et al. Chitosan-
coated PLGA nanoparticles: a sustained drug release
strategy for cell cultures. Colloids Surf B Biointerfaces.
2013;103:310-317. doi: 10.1016/j.colsurfb.2012.10.063.
31. Alqahtani S, Simon L, Astete CE, et al. Cellular uptake,
antioxidant and antiproliferative activity of entrapped
α-tocopherol and γ-tocotrienol in poly (lactic-co-glycolic)
acid (PLGA) and chitosan covered PLGA nanoparticles
(PLGA-Chi). J Colloid Interface Sci. 2015;445:243-251.
doi: 10.1016/j.jcis.2014.12.083.
32. Chuah LH, Roberts CJ, Billa N, Abdullah S, Rosli R.
Cellular uptake and anticancer effects of mucoadhesive
curcumin-containing chitosan nanoparticles. Colloids
Surf B Biointerfaces. 2014;116:228-236. doi: 10.1016/j.
colsurfb.2014.01.007.
33. Pawar D, Mangal S, Goswami R, Jaganathan KS.
Development and characterization of surface modified
PLGA nanoparticles for nasal vaccine delivery: effect of
mucoadhesive coating on antigen uptake and immune
Stomatology Edu Journal
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
adjuvant activity. Eur J Pharm Biopharm. 2013;85(3 Pt
A):550-559. doi: 10.1016/j.ejpb.2013.06.017.
Grabowski N, Hillaireau H, Vergnaud J, et al. Toxicity
of surface-modified PLGA nanoparticles toward lung
alveolar epithelial cells. Int J Pharm. 2013;454(2):686-694.
doi: 10.1016/j.ijpharm.2013.05.025.
Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima
N, Kawashima Y. Improved cellular uptake of chitosan-
modified PLGA nanospheres by A549 cells. Int
J Pharm. 2009;382(1-2):198-204. doi: 10.1016/j.
ijpharm.2009.07.023.
Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D,
Durán N. Chitosan-solid lipid nanoparticles as carriers for
topical delivery of tretinoin. Colloids Surf B Biointerfaces.
2012;93:36-40. doi: 10.1016/j.colsurfb.2011.11.051.
Hafner A, Lovrić J, Pepić I, Filipović-G rčić J. Lecithin/
chitosan nanoparticles for transdermal delivery of
melatonin. J Microencapsul. 2011;28(8):807-815. doi:
10.3109/02652048.2011.622053.
Blažević F, Milekić T, Romić MD, et al. Nanoparticle-
mediated interplay of chitosan and melatonin for
improved wound epithelialisation. Carbohydr Polym.
2016;146:445-454. doi: 10.1016/j.carbpol.2016.03.074.
Lee HY, Jeong YI, Choi KC. Hair dye-incorporated poly-γ-
glutamic acid/glycol chitosan nanoparticles based on ion-
complex formation. Int J Nanomedicine. 2011;6:2879-
2888. doi: 10.2147/IJN.S26458.
Sonvico F, Cagnani A, Rossi A, et al. Formation of self-
organized nanoparticles by lecithin/chitosan ionic
interaction. Int J Pharm. 2006;324(1):67-73.
Sahay G, Kim JO, Kabanov AV, Bronich TK. The exploitation
of differential endocytic pathways in normal and tumor
cells in the selective targeting of nanoparticulate
chemotherapeutic agents. Biomaterials. 2010;31(5):923-
933. doi: 10.1016/j.biomaterials.2009.09.101.
Rao W, Wang H, Han J, et al. Chitosan-decorated
doxorubicin-encapsulated nanoparticle targets and
eliminates tumor reinitiating cancer stem-like cells. ACS
Nano. 2015;9(6):5725-5740. doi: 10.1021/nn506928p.
Wang H, Agarwal P, Zhao S, et al. Hyaluronic acid-
decorated dual responsive nanoparticles of Pluronic
F127, PLGA, and chitosan for targeted co-delivery of
doxorubicin and irinotecan to eliminate cancer stem-
like cells. Biomaterials. 2015;72:74-89. doi: 10.1016/j.
biomaterials.2015.08.048.
Shabani Ravari N, Goodarzi N, Alvandifar F, et al.
Fabrication and biological evaluation of chitosan coated
hyaluronic acid-docetaxel conjugate nanoparticles in
CD44(+) cancer cells. Daru. 2016;24(1):21. doi: 10.1186/
s40199-016-0160-y.
Wang Y, Li P, Kong L. Chitosan-modified PLGA
nanoparticles with versatile surface for improved drug
delivery. AAPS PharmSciTech. 2013;14(2):585-592. doi:
10.1208/s12249-013-9943-3.
Bakhru SH, Altiok E, Highley C, et al. Enhanced cellular
uptake and long-term retention of chitosan-modified
iron-oxide nanoparticles for MRI-based cell tracking. Int
J Nanomedicine. 2012;7:4613-4623. doi: 10.2147/IJN.
S28294.
De Cicco F, Porta A, Sansone F, Aquino RP, Del
Gaudio P.Nanospray technology for an in situ gelling
nanoparticulate powder as a wound dressing.
Int J Pharm. 2014;473(1-2):30-37. doi: 10.1016/j.
ijpharm.2014.06.049.
Chuah LH, Roberts CJ, Billa N, Abdullah S, Rosli R.
Cellular uptake and anticancer effects of mucoadhesive
curcumin-containing chitosan nanoparticles. Colloids
Surf B Biointerfaces. 2014;116:228-236. doi: 10.1016/j.
colsurfb.2014.01.007.
Hillaireau H, Couvreur P. Nanocarriers’ entry into the
cell: relevance to drug delivery. Cell Mol Life Sci.
2009;66(17):2873-2896. doi: 10.1007/s00018-009-
0053-z.
Konstantinova V, Ibrahim M, Lie SA, et al. Nano-TiO 2
penetration of oral mucosa: in vitro analysis using 3D
organotypic human buccal mucosa models. J Oral Pathol
Med. 2017;46(3):214-222. doi: 10.1111/jop.12469.
CHITOSAN MODIFIED POLY(LACTIC-CO-GLYCOLIC) ACID NANOPARTICLES INTERACTION WITH
NORMAL, PRECANCEROUS KERATINOCYTES AND DENTAL PULP CELLS
25